Multifiling Mitra Indonesia Tbk PT operates within the Libraries sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Multifiling Mitra Indonesia Tbk PT with three other
miscellaneous service companies in Asia:
Carna Biosciences Inc
sales of 811.60 million Japanese Yen [US$7.21 million]
of which 88%
was Drug Discovery Support Business),
Human Metabolome Technologies Inc
(780.38 million Japanese Yen [US$6.93 million]
of which 90%
was Metabolome analysis business), and
BrightPath Biotherapeutics Co Ltd
based in Japan
(822.56 million Japanese Yen [US$7.30 million]
of which 100%
was Commerical Physical Research).
During the year ended December of 2016, sales at
Multifiling Mitra Indonesia Tbk PT were 100.15 billion Indonesian Rupiahs (US$7.40 million).
increase of 18.5%
versus 2015, when the company's sales were 84.50 billion Indonesian Rupiahs.
This was the fifth consecutive year of sales increases at Multifiling Mitra Indonesia Tbk PT
(and since 2011, sales have increased a total of 97%).